No price series to chart for GLAS.
GLAS is not in the screener universe; fundamentals are unavailable.
No price history for GLAS — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for GLAS, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | $4.58B | — |
| TLRY | Tilray Brands, Inc. | $3.59B | — |
| CRON | Cronos Group Inc. | $1.06B | — |
| USNA | USANA HEALTH SCIENCES INC | $429.1M | 40.1 |
| CGC | Canopy Growth Corp | $377.5M | — |
| SNDL | SNDL Inc. | $321.3M | — |
| NAGE | Niagen Bioscience, Inc. | $262.0M | 16.4 |
| CRLBF | Cresco Labs Inc. | $226.4M | — |
| ACB | AURORA CANNABIS INC | $153.0M | — |
| FTLF | FITLIFE BRANDS, INC. | $93.9M | 15.9 |
| BTMD | biote Corp. | $82.1M | 3.0 |
| AAWH | Ascend Wellness Holdings, Inc. | $79.2M | — |